ALT · Altimmune, Inc. · Investor Relations
$2.30
+0.07 (+3.14%)
At close · Oct 20
Return incl. dividend (before tax)
Market Cap
$441.56M
Shares
194.52M
Volume · Oct 20
2.31M
Avg daily vol (3M)
4.25M
Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Past events
| Date | Event | Type |
|---|---|---|
| 2026-09-30 | Stifel 2026 Virtual Cardiometabolic Forum | Webcast |
| 2026-09-10 | Wells Fargo 21st Annual Healthcare Conference | Conference |
| 2026-08-12 | Altimmune Second Quarter 2026 Earnings Conference Call | Earnings call |
| 2026-07-28 | Earnings conference call (announced in 8-K) | Earnings call |
| 2026-06-10 | Goldman Sachs 47th Annual Global Healthcare Conference | Conference |
| 2026-06-04 | 2026 Jefferies Global Healthcare Conference | Conference |
| 2026-05-29 | EASL Congress 2026 - Poster Presentations | Presentation |
| 2026-05-28 | EASL Congress 2026 - Oral Presentation | Presentation |
| 2026-05-27 | EASL Congress 2026 - Late-Breaking Poster | Event |
| 2026-05-13 | Altimmune First Quarter 2026 Earnings Conference Call | Earnings call |
| 2026-03-05 | Q4 Earnings conference call (announced in 8-K) | Earnings call |
Source: https://ir.altimmune.com/
Key facts
CIK
1326190
CUSIP
02155H200
13F (30d)
21 filings
21 filers
Visit website
Investor relations